Contagion Live interviewed Dr. Malone, CEO of RW Malone, MD on antiviral drugs against Zika

On Friday, February 24, 2017, at the First International Conference on Zika Virus, Robert W. Malone, MD, MS, discussed repurposing licensed drugs to serve as both therapy and prophylaxis for Zika. Contagion® sat down with Dr. Malone to discuss his research.   - See more at: http://www.contagionlive.com/news/repurposing-licensed-drugs-for-use-against-the-zika-virus#sthash.K7lwvhLC.dpuf

Robert Malone, CEO of RW Malone MD, LLC is at the World Health Organization, working on the Zika Virus

The World Health Organization has asked Robert W Malone, MD, MS to join a consultation/round panel to help find research and development for the Zika Virus outbreak.  He is presenting a target product profile and will be addressing the need for anti-viral treatments, such as the one that our new company, Atheric Pharmaceutical, LLC can provide.  These anti-virals are patent protected and can move into clinical trials very rapidly, even before the summer Olympics!

Principal Robert Malone, MD, MS was the keynote speaker at the VACCINES R&D-2015 A NEW ERA IN VACCINE DISCOVERY conference

Principal Robert Malone, MD, MS was the keynote speaker at the VACCINES R&D-2015 A NEW ERA IN VACCINE DISCOVERY conference in Baltimore, MD (November  2-4, 2015).  His talk was entitled: "Ebola Vaccine in 12 months, Global Village, and the Need for Speed."

The International Conference on Vaccines Research & Development (Vaccines R&D-2015) in Baltimore, brought together professors, researchers, scientists, academicians and other professionals in vaccine community to exchange and discuss their original research results, practical development experiences, technological achievements and new ideas for developing future vaccines.  The conference was a huge success and we are already looking forward to next year's conference!

21.jpg

The Harvard Medical School Global Clinical Trials program

Here is a photo from the Harvard Medical School Global Clinical Trials program workshop in London, Dec 2015. Principals Robert and Jill Malone are near the front. 
They are now at the half way mark in the yearlong program, which has been extremely valuable in teaching them about biostatistics, advanced stata techniques, and advancing their understanding of running clinical trials internationally, as well as domestically.

Effective Ebola vaccine in 12 months- it took a village, and hard work!

RW Malone MD LLC is proud to have played a key role in enabling the enormous success of developing an effective Ebola vaccine within 12 months. August 2014, colleagues at the Department of Defense/Defense Threat Reduction Agency asked us to step in and help NewLink manage the project and develop the contracts necessary to move the "orphan" PHAC/rVSV ZEBOV vaccine forward quickly. We got the project on track, recruited our client Focus Clinical Trials to team with USAMRIID/WRAIR to develop the immunoassays, put WHO leadership in touch with Pentagon leadership to expedite the initial WRAIR clinical trials, recruited the government of Norway to help fund the clinical research, used social media (LinkedIn) to recruit Merck Vaccines to join the project, recruited a management team, and lead the development of the BARDA and DTRA contracts - yielding over 200M$ in resources. Those were frightening times, but now we have a remarkably effective vaccine, developed in record time. The US Army Medical Corps, Medical Countermeasure Systems (MCS) and the DoD Defense Threat Reduction Agency (DTRA) took risks and got the job done, on time and on budget, with little fanfare, and we were grateful to have been able to serve and assist with this huge accomplishment.

  Robert took these photos during the Ebola crisis planning meetings at the World Health Organization last fall. Heads of states, the Director General and Assistant Director General of the WHO, the Assistant Secretary for Preparedness and Response for USA, ambassadors from most major countries -including the USA and UK, and CEOs from most of the major pharma vaccine companies were all there. The meetings were intense, passions were high and the world came together to develop a plan. Scary times.

Robert took these photos during the Ebola crisis planning meetings at the World Health Organization last fall. Heads of states, the Director General and Assistant Director General of the WHO, the Assistant Secretary for Preparedness and Response for USA, ambassadors from most major countries -including the USA and UK, and CEOs from most of the major pharma vaccine companies were all there. The meetings were intense, passions were high and the world came together to develop a plan. Scary times.

Kudos to Dr. Malone, DTRA, USAMRIID, PHAC, and Many Others

Jim Wilson, MD FAAP

Director at Ascel Bio World Infectious Disease Forecast Center

It is rare that I have the privilege to witness, on the ground floor, a major global public health event.  And even rarer to give public kudos to one of the silent heroes among a huge group of heroes who contributed to the process.  I am proud to present Dr. Robert Malone's heroic contribution to the Ebola fight:

RW Malone MD is proud to have played a key role in enabling the enormous success of developing an effective Ebola vaccine within 12 months. August 2014, colleagues at the Department of Defense/Defense Threat Reduction Agency asked us to step in and help NewLink manage the project and develop the contracts necessary to move the "orphan" PHAC/rVSV ZEBOV vaccine forward quickly. We got the project on track, recruited our client, Focus  Diagnostic Clinical Trials (FCT), to team with USAMRIID/WRAIR to develop and perform the immunoassays, put WHO leadership in touch with Pentagon leadership to expedite the initial WRAIR clinical trials, recruited the government of Norway to help fund the clinical research, used social media (LinkedIn) and then personal phone calls to recruit Merck Vaccines to join the project, recruited a management team, and lead the development of the BARDA and DTRA contracts - yielding over 200M$ in resources. Those were frightening times, but now we have a remarkably effective vaccine, developed in record time. The US Army Medical Corps, Medical Countermeasure Systems (MCS) and the DoD Defense Threat Reduction Agency (DTRA) took risks and got the job done, on time and on budget, with little fanfare, and we were grateful to have been able to serve and assist with this huge accomplishment.

While the above sounds like a promotion for Robert's consulting service, I am here to publicly say I watched him do this first-hand.  I want to also heartily acknowledge and congratulate DTRA, USAMRIID, and especially our colleagues in Canada's PHAC.  You all have done a terrific job here.  WELL DONE.

 https://www.linkedin.com/pulse/kudos-dr-malone-dtra-usamriid-phac-many-others-jim-wilson-md-faap